期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2009年非小细胞肺癌治疗研究进展 被引量：1

Research Progress on Treatment for Non-small Cell Lung Cancer in 2009
原文传递
导出
摘要 全文结合近年来影响非小细胞肺癌治疗的重要循证研究,尤其是2009年ASCO会议上的最新研究进展作一简介。
作者 陆舜 李子明
机构地区 上海交通大学附属上海市胸科医院肺部肿瘤临床医学中心
出处 《肿瘤学杂志》 CAS 2009年第8期693-697,共5页 Journal of Chinese Oncology
关键词 癌 非小细胞肺 药物疗法 研究进展
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[J]. N Engl J Med, 2005, 352(25):2589-2597.
  • 2Vincent MD, Butts C, Seymour L, et al. Updated survival analysis of JBR10: a randomized phase Ⅲ trial of vinorelbine/cisplatin versus observation in completely resected stage Ⅰ b and Ⅱ non-small cell lung cancer (NSCLC)[C]. J Clin Oncol, 27:15s, 2009 (suppl; abstr 7501).
  • 3FeliP E, Massuti B , Alonso G, et al. Surgery (S) alone, Preoperative(Preop) paclitaxel/carboplatin (PC) chemotherapy followed by S, or S followed by adjuvant (adj) PC chemotherapy in early-stage non-small cell lung cancer (NSCLC): Results of the NATCH multicenter, randomized phase Ⅲ trial[C]. J Clin Oncol, 27:15s, 2009 (suppl; abstr 7500).
  • 4Fouret P, Planchard D, Mendiboure J, et al. MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer [C]. J Clin Oncol, 27:18s, 2009 (suppl; abstr CRA7502).
  • 5Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [J]. N Engl J Med, 2006, 355(24):2542-2550.
  • 6Scagliotti GV, Parikh P, von Pawel J, et al. Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[C]. ASCO Annual Meeting, May 31, 2008; Chicago, IL; abstract 7505.
  • 7Peterson P, Park K, Fossella F, et al. Is pemetrexed more effective in patients with non-squamous histology? A retrospective analysis of a phase iii trial of pemetrexed vs docetaxel in previously treated patients with advanced non- small cell lung cancer (NSCLC) [C]. EuroPean Cancer Conference; September 23, 2007; Barcelona, Spain; abstract 6521.
  • 8Ciuleanu TE, Brodowicz T, Belani CP, et al. Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: a phase Ⅲ study[C]. ASCO Annual Meeting, May 31, 2008; Chicago, IL; abstract 8011.
  • 9Pirker R, Szczesna A, von Pawel J, et al. FLEX: A randomized, multicenter, phase Ⅲ study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) [J]. J Clin Oncol, 2008, 26(suppl): abstr 3.
  • 10O'Byrne K J, Bondarenko I, Barrios C, et al. Molecular and clinical predictors of outcome for cetuximab in non- small cell lung cancer(NSCLC): Data from the FLEX study [J]. J Clin Oncol, 27:15s, 2009 (suppl, abstr 8007).

同被引文献3

  • 1WINTON T,LIVINGSTON R,JOHNSON D,et al.Vinorelbine plus cisplatin vs.observation in resected non-small-cell lung cancer[J].N Engl J Med,2005,352(25):2589-2597.
  • 2FOURET P,PLANCHARD D,MENDIBOURE J,et al.MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer[J].J Clin Oncol,2009,27(Suppl):18.
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.

引证文献1

二级引证文献5

肿瘤学杂志
2009年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部